Logotype for Innoviva Inc

Innoviva (INVA) investor relations material

Innoviva H.C. Wainwright 27th Annual Global Investment Conference summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Innoviva Inc
H.C. Wainwright 27th Annual Global Investment Conference summary8 Sep, 2025

Business structure and strategy

  • Operates a three-part business: respiratory royalty portfolio, critical care/infectious disease therapeutics (IST), and strategic healthcare investments.

  • Royalty portfolio expected to generate over $1 billion in revenue over the next five years.

  • IST platform includes four marketed products and one late-stage pipeline candidate, with $130 million in sales and over 50% annual growth.

  • Strategic healthcare investments valued at approximately $450 million, offering attractive risk-reward profiles.

  • Focus on capital allocation to high unmet medical needs and long-term value creation.

Financial performance and growth

  • IST's global product sales grew by over 60% in 2024, driven by GIAPREZA® and XACDURO® launches.

  • Royalty business continues to outperform analyst expectations, providing stable cash flows.

  • Over 50% year-on-year growth in US product sales from therapeutics in the first half of the year.

  • Royalty streams from ANORO® ELLIPTA® and RELVAR®/BREO® ELLIPTA® are resilient and generate significant revenue, especially ex-US.

  • Both royalty and IST products have patent protection into the 2030s, supporting long-term revenue durability.

Product portfolio and innovation

  • IST built on differentiated products with strong synergies and a highly experienced team.

  • GIAPREZA® relaunch supported by new commercial strategy and sales force optimization.

  • XACDURO® targets acinetobacter infections and has had a highly successful launch.

  • XERAVA® addresses rising ESBL-mediated resistance; ZEVTERA® launched in the US for Staphylococcus bacteremia.

  • Zoliflodacin, a late-stage candidate for resistant gonorrhea, has a PDUFA date in mid-December.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Innoviva earnings date

Logotype for Innoviva Inc
Q3 20254 Nov, 2025
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Innoviva earnings date

Logotype for Innoviva Inc
Q3 20254 Nov, 2025

The essential earnings season companion

The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Innoviva Inc. is a biopharmaceutical company focused on managing and developing royalty portfolios. The company's primary business involves the commercialization of its portfolio of royalties, primarily derived from partnerships with pharmaceutical companies. Innoviva's portfolio includes interests in respiratory medicines and other therapeutic areas, where it receives royalties from the sale of these products. The company is involved in actively managing its royalty portfolio and exploring potential acquisitions or partnerships to expand its interests in healthcare assets. The company is headquartered in Burlingame, California, and its shares are listed on the NASDAQ.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage